Pharmacotherapy: statins and new-onset diabetes—the important questions

Preiss, D. and Sattar, N. (2012) Pharmacotherapy: statins and new-onset diabetes—the important questions. Nature Reviews Cardiology, 9(4), pp. 190-192. (doi: 10.1038/nrcardio.2012.15)

Full text not currently available from Enlighten.

Publisher's URL:


Observational data from the Women's Health Initiative show a 48% increased risk of developing diabetes mellitus with statins. Results from two meta-analyses of randomized trials of statins with 120,000 participants have indicated a dose-dependent, but more-modest, relationship between statins and new-onset diabetes. Careful interpretation of pharmacoepidemiological data is required.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Preiss, Dr David and Sattar, Professor Naveed
Authors: Preiss, D., and Sattar, N.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Nature Reviews Cardiology

University Staff: Request a correction | Enlighten Editors: Update this record